Design Therapeutics, Inc. DSGN
12.12
(0.24)
(1.94%)
as of 25 Sep
- Market cap
- $809.3M
- P/E
- 0.0×
Follow DSGN
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | 0.00 | — | — |
P/S ratio |
— | — | — | — | — | 2,377.24 | — | — |
P/FCF ratio |
— | — | — | — | — | 0.00 | — | — |
P/Operating CF |
— | — | — | — | — | (188.91) | — | — |
P/B ratio |
— | — | — | — | — | 0.00 | — | — |
Price to Tangible BV |
— | — | — | — | — | 0.00 | — | — |
EV/Sales |
— | — | — | — | — | 2,217.54 | — | — |
EV/EBITDA |
— | — | — | — | — | 0.00 | — | — |
EV/Operating CF |
— | — | — | — | — | (57.81) | — | — |
EV/FCF |
— | — | — | — | — | (57.81) | — | — |
Quick Ratio |
16.84 | 29.01 | 29.29 | 30.66 | 72.70 | 15.49 | 0.02 | — |
Current Ratio |
17.14 | 29.31 | 29.58 | 31.10 | 72.96 | 15.55 | 0.02 | — |
Net Debt/EBITDA |
2.68 | 3.61 | 3.37 | 4.82 | 10.73 | 4.30 | (0.23) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 772.22% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.19) | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | — |
Operating CF/Net income |
0.78 | 0.87 | 0.88 | 0.81 | 0.83 | 1.05 | 0.07 | — |
Capex/Depreciation |
0.07 | 0.06 | 0.05 | 0.89 | (29.58) | 1.15 | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (30.70%) | (19.08%) | (22.10%) | (17.85%) | (19.16%) | 110.72% | 27.37% | — | |
| (29.18%) | (18.31%) | (21.20%) | (17.30%) | (16.64%) | (45.24%) | (4,548.89%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(32.97%) | (20.58%) | (24.17%) | (19.40%) | (9.31%) | (24.37%) | 56.22% | — |
Average Days of Receivables |
— | — | — | 0.00 | 0.00 | 0.00 | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2,681.42% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,104.42% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 199.12% | — | — |
Graham Net Nets |
— | — | — | — | — | (0.02) | — | — |
Graham Number |
— | — | — | — | — | 2.91 | — | — |
Earnings Yield |
— | — | — | — | — | (1.54%) | — | — |
Free Cash Flow Yield |
— | — | — | — | — | (1.61%) | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | — |
Operating CF per Share |
(0.95) | (0.76) | (1.05) | (0.92) | (0.64) | (0.55) | 0.00 | — |
Capex per Share |
0.00 | (0.01) | 0.00 | (0.02) | (0.03) | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(0.95) | (0.77) | (1.05) | (0.94) | (0.67) | (0.55) | 0.00 | — |
Cash per Share |
3.83 | 4.34 | 5.03 | 5.93 | 8.36 | 2.28 | 0.00 | — |
Shareholders Equity per Share |
3.71 | 4.28 | 4.96 | 5.88 | 8.32 | (0.72) | (0.07) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
3.71 | 4.28 | 4.96 | 5.88 | 8.32 | (0.72) | (0.07) | — |
Free Cash Flow |
(54.55) | (43.44) | (58.82) | (52.20) | (30.91) | (8.74) | (0.14) | — |
Working Capital |
210.73 | 239.58 | 274.96 | 324.34 | 380.15 | 33.90 | (3.64) | — |
Capital Expenditures |
(0.19) | (0.34) | (0.26) | (0.88) | (1.54) | (0.08) | — | — |
Net Current Asset Value |
210.08 | 238.04 | 272.63 | 321.29 | 377.01 | (11.60) | (3.64) | — |
EV/EBIT |
— | — | — | — | — | 0.00 | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (3,663.72%) | 0.00% | — |
Price to Operating Income |
— | — | — | — | — | 0.00 | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
(2.68) | (3.97) | (3.28) | (0.51) | 0.03 | (0.93) | — | — |
Cash ROIC |
(12.80%) | (9.13%) | (10.77%) | (8.10%) | (4.03%) | (35.28%) | 4.84% | — |
Accounts Receivable Turnover |
— | — | — | 0.00 | 0.00 | 3.77 | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | — | — |
Average Receivables |
— | — | — | 0.61 | 0.06 | 0.06 | — | — |
Average Payables |
2.25 | 2.06 | 2.48 | 2.32 | 1.51 | 1.51 | — | — |
Average Assets |
239.15 | 270.87 | 315.39 | 365.85 | 213.54 | 18.30 | 0.05 | — |
Average Common Equity |
227.30 | 259.89 | 302.50 | 354.72 | 185.41 | (7.48) | (7.48) | — |
Columns are period end dates